|
|||||
|
|
| Comment on “Disease exacerbation is common in inflammatory bowel disease patients treated with immune checkpoint inhibitors for malignancy” | |
| 摘 要： | |
| 收稿时间： | 2022-03-20 |
| 点击此处可从《World Journal of Clinical Cases》浏览原始摘要信息 | |
|
||||||||||||
|
||||||||||||
|
||||||||||||
|
|
|
|
| 设为首页 | 免责声明 | 关于勤云 | 加入收藏 |
|
Copyright©北京勤云科技发展有限公司 京ICP备09084417号 |